Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person13
Veradermics, Inc
Company
Veradigm Inc.
Company
VERU INC.
Company
Verastem, Inc.
Company
VERACYTE, INC.
Company
Vera Bradley, Inc.
Company
Vera Therapeutics, Inc.
Company
Vertex, Inc.
Company
Verisk Analytics, Inc.
Company
VerifyMe, Inc.
Company
Veritone, Inc.
Company
VEEA INC.
Company
Fermi Inc.
Company
Primary record7
Veradermics, Inc filed 8-K
Item 7.01. Regulation FD Disclosure. On October 19, 2026, Veradermics, Incorporated (the “Company”) issued a press release announcing positive topline data from the Phase 3 clinical trial, Study ‘304’ evaluating VDPHL01
JPMORGAN CHASE & CO filed SCHEDULE 13G
0000019617-26-000348.txt : 20261013 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0000019617 XXXXXXXX LIVE Common stock, par value $0.00001 per share 09/30/2026 0001827635 Veradermics, Inc 922967104 470 James St. New
Veradermics, Inc filed 4
SEC form 4 filed by Veradermics, Inc (CIK 1827635) on 2026-08-18.
Veradermics, Inc filed 4
SEC form 4 filed by Veradermics, Inc (CIK 1827635) on 2026-08-14.
Veradermics, Inc filed SCHEDULE 13D/A
; or (j) Any action similar to any of those enumerated above. SR One Fund II Aggregator is the record owner of the SR One Fund II Aggregator Shares. As the general partner of SR One Fund II Aggregator, SR One Partners II
Veradermics, Inc filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 11, 2026, Veradermics, Incorporated issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press rele
Veradermics, Inc filed S-1
SEC form S-1 filed by Veradermics, Inc (CIK 1827635) on 2026-08-07.